View PHARMExcel at 15: Looking Forward

PHARMExcel at 15: Looking Forward

Yvanne Enever, PHARMExcel CEO reflects on 15 years’ CRO success and what lies ahead for PHARMExcel, its clients and partners.

Read More

View PHARMExcel named among the best CRO specialist providers

PHARMExcel named among the best CRO specialist providers

PHARMExcel receives honours for its clinical trial management services and partnerships.

Read More

View PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research

PHARMExcel celebrates 15 years’ CRO impact in clinical trials for NHS, investigator and biotech research

Celebrating 15 years of delivering quality-driven clinical trials in the academic and commercial sector.

Read More

View PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials

PHARMExcel awarded for impactful CRO services in ophthalmology clinical trials

High praise for the PHARMExcel team from the judges at the OBN Awards for exceptional services.

Read More

View Why choose an ISO 9001-compliant CRO?

Why choose an ISO 9001-compliant CRO?

Is your CRO certified to ISO 9001 standards? Discover why this matters.

Read More

View PHARMExcel nominated Best Contract Research Organisation (Specialist Providers) by SCRIP Awards 2024

PHARMExcel nominated Best Contract Research Organisation (Specialist Providers) by SCRIP Awards 2024

PHARMExcel nominated Best Contract Research Organisation – Specialists NHS Provider in Clinical Trial Delivery

Read More

View Your Research, Our Priority: PHARMExcel’s Commitment to Delivering Quality Every Time

Your Research, Our Priority: PHARMExcel’s Commitment to Delivering Quality Every Time

Hear how PHARMExcel strikes the right balance between quality and speed for its clinical trial delivery

Read More

View ATMP Oncology Study: The first-in man trial for a Biotech’s novel therapy to prime the patient’s natural killer cells to attack their cancer

ATMP Oncology Study: The first-in man trial for a Biotech’s novel therapy to prime the patient’s natural killer cells to attack their cancer

First-in-man clinical trial for INmune Bio’s novel therapy to prime the patient’s natural killer cells to attack their cancer.

Read More

View PHARMExcel Named Finalist for Most Impactful CRO of the Year at OBN Awards

PHARMExcel Named Finalist for Most Impactful CRO of the Year at OBN Awards

PHARMExcel nominated for Most Impactful CRO in OBN Life Sciences Awards

Read More